Dic(17;18)(p11.2;p11.2) is a recurring abnormality in chronic lymphocytic leukaemia associated with aggressive disease

British Journal of Haematology

Volumn 148, Issue 5, 2010, Pages 754-759

  Woyach, Jennifer A ^a   Heerema, Nyla A ^b   Zhao, John ^b   McFaddin, Andrew ^b   Stark, Amy ^c   Lin, Thomas S ^a   Andritsos, Leslie A ^a   Blum, Kristie A ^a   Flynn, Joseph M ^a   Jones, Jeffrey A ^a   Byrd, John C ^a,d  

^a Division of Hematology and Oncology   (United States)

^b Department of Pathology ^*  (United States)

^c Center for Biostatistics   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

Chronic lymphocytic leukemia; Cytogenetic abnormalities; Dic(17; 18)(p11.2; p11.2); FISH; Prognostic factors

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN;

ADULT; AGED; ARTICLE; CHROMOSOME 17P; CHROMOSOME 18P; CHRONIC LYMPHATIC LEUKEMIA; CYTOGENETICS; DICENTRIC CHROMOSOME; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; TONSIL CANCER;

ADULT; AGED; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 11; CYTOGENETIC ANALYSIS; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; TRANSLOCATION, GENETIC;

EID: 76449117565     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.08007.x     Document Type: Article

References (28)

1. Adeyinka, A., Wei, S. Sanchez, J. (2007) Loss of 17p is a major consequence of whole-arm chromosome translocations in hematologic malignancies. Cancer Genetics and Cytogenetics, 173, 136 143.
2. Athanasiadou, A., Stamatopoulos, K., Tsompanakou, A., Gaitatzi, M., Kalogiannidis, P., Anagnostopoulos, A., Fassas, A. Tsezou, A. (2006) Clinical, immunophenotypic, and molecular profiling of trisomy 12 in chronic lymphocytic leukemia and comparison with other karyotypic subgroups defined by cytogenetic analysis. Cancer Genetics and Cytogenetics, 168, 109 119.
3. Binet, J.L., Auquier, A., Dighiero, G., Chastang, C., Piguet, H., Goasguen, J., Vaugier, G., Potron, G., Colona, P., Oberling, F., Thomas, M., Tchernia, G., Jacquillat, C., Boivin, P., Lesty, C., Duault, M.T., Monconduit, M., Belabbes, S. Gremy, F. (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer, 48, 198 206.
4. Byrd, J.C., Stilgenbauer, S. Flinn, I.W. 2004) Chronic lymphocytic leukemia. Hematology. American Society of Hematology Educational Program Book, 2004, 163 183.
5. Byrd, J.C., Gribben, J.G., Peterson, B.L., Grever, M.R., Lozanski, G., Lucas, D.M., Lampson, B., Larson, R.A., Caligiuri, M.A. Heerema, N.A. (2006) Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy. Journal of Clinical Oncology, 24, 437 443.
6. Callet-Bauchu, E., Salles, G., Gazzo, S., Poncet, C., Morel, D., Pages, J., Coiffier, B., Coeur, P. Felman, P. (1999) Translocations involving the short arm of chromosome 17 in chronic B-lymphoid disorders: frequent occurrence of dicentric rearrangements and possible association with adverse outcome. Leukemia, 13, 460 468.
7. Chena, C., Cerretini, R., Noriega, M.F., Narbaitz, M., Scolnik, M., Palacios, M.F., Neme, D., Bruno, S. Slavutsky, I. (2002) Cytogenetic, FISH, and molecular studies in a case of B-cell chronic lymphocytic leukemia with karyotypic evolution. European Journal of Haematology, 69, 309 314.
8. Cordone, I., Masi, S., Mauro, F.R., Soddu, S., Morsilli, O., Valentini, T., Vegna, M.L., Guglielmi, C., Mancini, F., Giuliacci, S., Sacchi, A., Mandelli, F. Foa, R. (1998) p53 expression in B-cell chronic lymphocytic leukemia: a marker of disease progression and poor prognosis. Blood, 91, 4342 4349.
9. Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S.M., Schulman, P., Vinciguerra, V.P., Rai, K.R., Ferrarini, M. Chiorazzi, N. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood, 94, 1840 1847.
10. Dohner, H., Fischer, K., Bentz, M., Hansen, K., Benner, A., Cabot, G., Diehl, D., Schlenk, R., Coy, J. Stilgenbauer, S. (1995) p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood, 85, 1580 1589.
11. Dohner, H., Stilgenbauer, S., Benner, A., Leupolt, E., Krober, A., Bullinger, L., Dohner, K., Bentz, M. Lichter, P. (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. New England Journal of Medicine, 343, 1910 1916. (Pubitemid 32064784)
12. Espinet, B., Sole, F., Lloveras, E., Abella, E., Besses, C., Woessner, S. Florensa, L. (2000) Dicentric (17;18) in a case of atypical B-cell chronic lymphocytic leukemia. Cancer Genetics and Cytogenetics, 121, 194 197.
13. Fenaux, P., Preudhomme, C., Lai, J.L., Quiquandon, I., Jonveaux, P., Vanrumbeke, M., Sartiaux, C., Morel, P., Loucheux-Lefebvre, M.H. Bauters, F. (1992) Mutations of the p53 gene in B-cell chronic lymphocytic leukemia: a report on 39 cases with cytogenetic analysis. Leukemia, 6, 246 250.
14. Fink, S.R., Smoley, S.A., Stockero, K.J., Paternoster, S.F., Thorland, E.C., Van Dyke, D.L., Shanafelt, T.D., Zent, C.S., Call, T.G., Kay, N.E. Dewald, G.W. (2006) Loss of TP53 is due to rearrangements involving chromosome region 17p10 approximately p12 in chronic lymphocytic leukemia. Cancer Genetics and Cytogenetics, 167, 177 181.
15. Grever, M.R., Lucas, D.M., Dewald, G.W., Neuberg, D.S., Reed, J.C., Kitada, S., Flinn, I.W., Tallman, M.S., Appelbaum, F.R., Larson, R.A., Paietta, E., Jelinek, D.F., Gribben, J.G. Byrd, J.C. (2007) Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997. Journal of Clinical Oncology, 25, 799 804.
16. Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G. Stevenson, F.K. (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood, 94, 1848 1854.
17. Juliusson, G., Oscier, D.G., Fitchett, M., Ross, F.M., Stockdill, G., Mackie, M.J., Parker, A.C., Castoldi, G.L., Guneo, A. Knuutila, S. (1990) Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. New England Journal of Medicine, 323, 720 724.
18. Juliusson, G., Gahrton, G. for the International Working Party on Chromosomes in CLL (IWCCLL). (1991) Cytogenetic findings and survival in B-cell chronic lymphocytic leukemia. Second IWCCLL compliation of data on 662 patients. Leukemia & Lymphoma, 5, 21 25.
19. Karhu, R., Tobin, G., Thunberg, U., Vilpo, L., Sundstrom, C., Knuutila, S., Rosenquist, R. Vilpo, J. (2003) More extensive genetic alterations in unmutated than in hypermutated cases of chronic lymphocytic leukemia. Genes, Chromosomes and Cancer, 37, 417 420.
20. Krober, A., Seiler, T., Benner, A., Bullinger, L., Bruckle, E., Lichter, P., Dohner, H. Stilgenbauer, S. (2002) V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood, 100, 1410 1416. (Pubitemid 34864299)
21. Maloum, K., Davi, F., Merle-Beral, H., Pritsch, O., Magnac, C., Vuillier, F., Dighiero, G., Troussard, X., Mauro, F.F. Benichou, J. (2000) Expression of unmutated VH genes is a detrimental prognostic factor in chronic lymphocytic leukemia. Blood, 96, 377 379.
22. Oscier, D.G., Gardiner, A.C., Mould, S.J., Glide, S., Davis, Z.A., Ibbotson, R.E., Corcoran, M.M., Chapman, R.M., Thomas, P.W., Copplestone, J.A., Orchard, J.A. Hamblin, T.J. (2002) Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood, 100, 1177 1184.
23. Rai, K.R., Sawitsky, A., Cronkite, E.P., Chanana, A.D., Levy, R.N. Pasternack, B.S. (1975) Clinical staging of chronic lymphocytic leukemia. Blood, 46, 219 234.
24. Schaffer, L.G. Tommerup, N. (2005) ISCN (2005): An International System for Human Cytogenetic Nomenclature. S. Karger, Basel.
25. Stankiewicz, P., Shaw, C.J., Dapper, J.D., Wakui, K., Shaffer, L.G., Withers, M., Elizondo, L., Park, S.S. Lupski, J.R. (2003) Genome architecture catalyzes nonrecurrent chromosomal rearrangements. American Journal of Human Genetics, 72, 1101 1116.
26. Van Den Neste, E., Robin, V., Francart, J., Hagemeijer, A., Stul, M., Vandenberghe, P., Delannoy, A., Sonet, A., Deneys, V., Costantini, S., Ferrant, A., Robert, A. Michaux, L. (2007) Chromosomal translocations independently predict treatment failure, treatment-free survival and overall survival in B-cell chronic lymphocytic leukemia patients treated with cladribine. Leukemia, 21, 1715 1722.
27. Vasconcelos, Y., Davi, F., Levy, V., Oppezzo, P., Magnac, C., Michel, A., Yamamoto, M., Pritsch, O., Merle-Beral, H., Maloum, K., Ajchenbaum-Cymbalista, F. Dighiero, G. (2003) Binet's staging system and VH genes are independent but complementary prognostic indicators in chronic lymphocytic leukemia. Journal of Clinical Oncology, 21, 3928 3932.
28. Wattel, E., Preudhomme, C., Hecquet, B., Vanrumbeke, M., Quesnel, B., Dervite, I., Morel, P. Fenaux, P. (1994) p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood, 84, 3148 3157.